Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Psychopharmacologic Drugs Advisory Committee
December 13, 2006
Jean Bronstein R.N., M.S.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
Andrew Leon, Ph.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
Bruce Pollock, M.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
Page updated:
November 27, 2006
|